NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) — Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve…
Read More: https://www.globenewswire.com/news-release/2024/05/23/2887173/0/en/Tourmaline-Bio-to-Present-at-the-Jefferies-Global-Healthcare-Conference.html
Stay updated with the latests analysis and insights fromm etfsector.com